Protopic Adherence and Efficacy in Korean Eczema Patient

Completed

• Conditions: Atopic Dermatitis

• Registration Number: NCT02126176
• Lead Sponsor: Pusan National University Hospital

Brief Summary

The purpose of this study is to determine whether the dosage of 0.1% tacrolimus ointment applied on unit area of eczema influence the efficacy of treatment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-04-24
• Study First Submitted QC: 2014-04-27
• Study First Posted: 2014-04-29
• Study Start: 2014-05
• Status Verified: 2016-03
• Primary Completion: 2016-03
• Study Completion: 2016-03
• Last Update Submitted: 2016-03-28
• Last Update Posted: 2016-03-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• at least 19 years of age with a diagnosis of atopic dermatitis
• treated with protopic 0.1% ointment

Exclusion Criteria

• treated with other medication or topical agent
• skin lesion on the scalp or hand and foot
• pregnant women/lactating women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical assessments of erythema, scaling, and pruritus	2 weeks	itching VAS scale

Trial Locations

Locations (1)

Department of dermatology, Pusan National University Hospital; 🇰🇷 Busan, Korea, Republic of